Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析

◆英語タイトル:Miragen Therapeutics Inc (MGEN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5264
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Miragen Therapeutics Inc (MGEN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Miragen Therapeutics, Inc. (Miragen) is a clinical stage biopharmaceutical company. It discovers and develops RNA-targeted therapeutics with a focus on microRNAs and their role in diseases. The company is developing its pipeline products for the treatment of Cutaneous T-Cell Lymphoma (CTCL), Adult T-Cell Lymphoma/Leukemia, Diffuse Large-B Cell Lymphoma, Chronic Lymphocytic Leukemia, ALS, Heart Failure, Incisional Complications, Cutaneous Fibrosis, Idiopathic Pulminary Fibrosis and Other Fibrotic Indications. The pipeline development is focused on microRNA platform that regulate gene expression and influences the pathways responsible for many disease processes. Miragen is headquartered in Boulder, Colorado, the US.

Miragen Therapeutics Inc Key Recent Developments

Aug 07,2018: miRagen Therapeutics announces second quarter 2018 financial results
May 09,2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update
Mar 14,2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Jan 05,2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris
Nov 08,2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Miragen Therapeutics Inc – Key Facts 6
Miragen Therapeutics Inc – Key Employees 7
Miragen Therapeutics Inc – Key Employee Biographies 8
Miragen Therapeutics Inc – Major Products and Services 9
Miragen Therapeutics Inc – History 10
Miragen Therapeutics Inc – Company Statement 11
Miragen Therapeutics Inc – Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 – Company Analysis 13
Company Overview 13
Miragen Therapeutics Inc – Business Description 14
R&D Overview 14
Miragen Therapeutics Inc – Corporate Strategy 15
Miragen Therapeutics Inc – SWOT Analysis 16
SWOT Analysis – Overview 16
Miragen Therapeutics Inc – Strengths 16
Miragen Therapeutics Inc – Weaknesses 17
Miragen Therapeutics Inc – Opportunities 18
Miragen Therapeutics Inc – Threats 19
Miragen Therapeutics Inc – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 24
Financial Performance 24
Financial Ratios – Interim Ratios 25
Financial Ratios – Ratio Charts 26
Section 4 – Company’s Lifesciences Financial Deals and Alliances 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 28
Miragen Therapeutics Inc, Recent Deals Summary 29
Section 5 – Company’s Recent Developments 30
Aug 07, 2018: miRagen Therapeutics announces second quarter 2018 financial results 30
May 09, 2018: miRagen Therapeutics Reports First Quarter 2018 Financial Results and Provides Corporate Update 32
Mar 14, 2018: miRagen Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update 34
Jan 05, 2018: miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris 36
Nov 08, 2017: miRagen Therapeutics Reports Third Quarter 2017 Financial Results and Provides Corporate Update 37
Aug 11, 2017: miRagen Therapeutics Reports Second Quarter 2017 Financial Results and Provides Corporate Update 39
May 10, 2017: miRagen Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update 41
Mar 31, 2017: miRagen Therapeutics Provides Corporate Update 43
Section 6 – Appendix 44
Methodology 44
Ratio Definitions 44
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Miragen Therapeutics Inc, Key Facts 6
Miragen Therapeutics Inc, Key Employees 7
Miragen Therapeutics Inc, Key Employee Biographies 8
Miragen Therapeutics Inc, Major Products and Services 9
Miragen Therapeutics Inc, History 10
Miragen Therapeutics Inc, Subsidiaries 12
Miragen Therapeutics Inc, Key Competitors 20
Miragen Therapeutics Inc, Ratios based on current share price 21
Miragen Therapeutics Inc, Annual Ratios 22
Miragen Therapeutics Inc, Annual Ratios (Cont...1) 23
Miragen Therapeutics Inc, Interim Ratios 25
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals By Type, 2012 to YTD 2018 28
Miragen Therapeutics Inc, Recent Deals Summary 29
Currency Codes 44
Capital Market Ratios 44
Equity Ratios 45
Profitability Ratios 45
Cost Ratios 46
Liquidity Ratios 46
Leverage Ratios 47
Efficiency Ratios 47

List of Figures
Miragen Therapeutics Inc, Performance Chart (2013 - 2017) 24
Miragen Therapeutics Inc, Ratio Charts 26
Miragen Therapeutics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 27
Miragen Therapeutics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 28

★海外企業調査レポート[Miragen Therapeutics Inc (MGEN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Grifols SA (GRF):企業の財務・戦略的SWOT分析
    Grifols SA (GRF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Dana Brevini Spa:企業の戦略・SWOT・財務分析
    Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Cleco Corporate Holdings LLC:企業の発電所・SWOT分析2018
    Cleco Corporate Holdings LLC - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Neos Therapeutics Inc (NEOS):製薬・医療:M&Aディール及び事業提携情報
    Summary Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded pharmaceuticals. The company’s portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years …
  • Noble Corporation Plc (NE):企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • WebMD Health Corp:企業の戦略的SWOT分析
    WebMD Health Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Huttig Building Products Inc:企業の戦略・SWOT・財務情報
    Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report Summary Huttig Building Products Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Johnson Outdoors Inc (JOUT):企業の財務・戦略的SWOT分析
    Johnson Outdoors Inc (JOUT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Liberty Media Corp (LSTZA):企業の財務・戦略的SWOT分析
    Liberty Media Corp (LSTZA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ashtead Group Plc (AHT):企業の財務・戦略的SWOT分析
    Ashtead Group Plc (AHT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Scripps Networks Interactive, Inc.:企業のM&A・事業提携・投資動向
    Scripps Networks Interactive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Scripps Networks Interactive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Grupo Nutresa SA (NUTRESA):企業の財務・戦略的SWOT分析
    Grupo Nutresa SA (NUTRESA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Kewpie Corporation:戦略・SWOT・企業財務分析
    Kewpie Corporation - Strategy, SWOT and Corporate Finance Report Summary Kewpie Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hamon Research-Cottrell Inc:企業の戦略的SWOT分析
    Hamon Research-Cottrell Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Copelouzos group-エネルギー分野:企業M&A・提携分析
    Summary Copelouzos group (Copelouzos) is an energy company that offers business development services. The company’s services include energy production and training, equipment supply, wastes management, natural gas, and concession and property services. It’s waste management services include residues …
  • Boardwalk Pipeline Partners LP:企業の戦略・SWOT・財務分析
    Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report Summary Boardwalk Pipeline Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Musgrave Group Plc:戦略・SWOT・企業財務分析
    Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report Summary Musgrave Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆